Webinar: The Evolution of Accelerated Access Pathways in Canada

This timely and insightful webinar explored recent developments accelerating access to new medicines for patient and prescribers across Canada.

On Wednesday, June 25, the Resilient Healthcare Coalition hosted an in-depth conversation exploring the following important questions: How far have we really come since June 2024? Can these new pathways deliver on their promise? And what will it take for Canada to match global leaders in ensuring patients get access to novel therapies faster?

This discussion was anchored by an insightful presentation from Allison Wills, Partner at 20Sense, and also featured key contributions from three impressive and diverse panelists:

• Peter Dyrda, Director, Pharmaceutical Review at Canada’s Drug Agency

• John Snowden, Executive Director of Value, Access & Policy at Amgen Canada Inc

• Sabrina Hanna, Chief Change Officer, The Cancer Collaborative

This webinar brought together healthcare professionals, policymakers, industry stakeholders, and patient advocates to discuss not only recent successes but also the biggest opportunities for future impact.